Evidence map›Paper›PMID 39633230›Full record

ArticleDigestive diseases and sciences2025

Characteristics and Risk Factors for Postoperative Bleeding Following Endoscopic Resection of Esophageal Squamous Neoplasms.

Daiki Kitagawa, Takashi Kanesaka, Ryu Ishihara, Yasuhiro Tani, Yuki Okubo, Yuya Asada, Tomoya Ueda, Atsuko Kizawa, Takehiro Ninomiya, Yoshiaki Ando and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Daiki KitagawaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Takashi KanesakaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan. takashikanesaka@oici.jp.
Ryu IshiharaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Yasuhiro TaniDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Yuki OkuboDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Yuya AsadaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Tomoya UedaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Atsuko KizawaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Takehiro NinomiyaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Yoshiaki AndoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Gentaro TanabeDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Yuta FujimotoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Hitoshi MoriDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Minoru KatoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Shunsuke YoshiiDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Satoki ShichijoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Sachiko YamamotoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Koji HigashinoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Noriya UedoDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Tomoki MichidaDepartment of Gastrointestinal Oncology, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Yasuhiro FujiwaraDepartment of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReports on postoperative bleeding after esophageal endoscopic resection are limited.

aimsThis study aimed to identify the clinical characteristics and risk factors for postoperative bleeding following endoscopic resection of esophageal neoplasms.

methodsThis single-center, retrospective study included consecutive patients who underwent endoscopic resection for esophageal squamous cell carcinoma or squamous intraepithelial neoplasm between January 2018 and December 2022. We investigated the incidence, timing, severity, and risk factors for postoperative bleeding.

resultsOf 1288 patients, 1062 (82%) underwent endoscopic submucosal dissection, and 226 (18%) underwent endoscopic mucosal resection. Postoperative bleeding occurred in seven (0.5%) patients (95% confidence interval [CI] 0.2-1.1%; median postoperative day 8 [range, 4-17 days]). In these seven patients, hemoglobin concentration decreased by a median of 3.0 g/dL (range, 1.6-6.8 g/dL). Antithrombotic agent use, resection wound circumference, and specimen size were significantly associated with postoperative bleeding (P < 0.001, P = 0.002, and P = 0.024, respectively). Among 43 patients who received direct oral anticoagulants (DOACs), postoperative bleeding occurred in four (9%) patients (95% CI 2.6-22.1%). DOACs were significantly associated with postoperative bleeding even after propensity score matching (4/40 [10%] vs. 0/80 [0%], respectively; P = 0.011).

conclusionsThe overall bleeding rate following esophageal endoscopic resection was 0.5%, with a delayed onset, leading to anemia. DOACs emerged as the most significant risk factor for postoperative bleeding.

Indexed as

Endoscopic Mucosal ResectionEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagectomyEsophagoscopyPostoperative HemorrhageAgedAged, 80 and overFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsEndoscopic mucosal resectionEndoscopyEsophageal neoplasmsEsophageal squamous cell carcinomaGastrointestinal hemorrhage

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.